カテゴリー： IMARC, 世界, 医療/バイオ

トランスフェクション試薬＆機器の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：Transfection Reagents and Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書（IMARC23FE0182）◆商品コード：IMARC23FE0182
◆発行会社（リサーチ会社）：IMARC
◆発行日：2023年2月1日
◆ページ数：145
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

IMARC社の本調査資料によると、世界のトランスフェクション試薬＆機器市場規模が2022年を基準に899.2百万ドルに達しています。今後、2028年には1,170百万ドルになり、2023年から2028年の間に4.2％の成長率を示すと見込まれます。本資料では、トランスフェクション試薬＆機器の世界市場を調査し、序論、範囲・手法、エグゼクティブサマリー、イントロダクション、製品別（試薬、機器）分析、技術別（生化学ベーストランスフェクション、物理的トランスフェクション、ウイルスベクターベーストランスフェクション）分析、用途別（生物医学研究、タンパク質生産、治療的送達）分析、エンドユーザー別（医薬品＆バイオテクノロジー企業、学術＆研究機関）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東・アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況など、以下のように掲載しています。また、企業情報として、Bourn Hall Clinic, CARE Fertility, Circle Surrogacy & Egg Donation, Extraordinary Conceptions, Growing Generations LLC, Houston Fertility Center, IVIRMA Global, Max Healthcare, New Hope Fertility Center, Nova IVF, Ovation Fertility and Scanfert Clinic.などが含まれています。
・序論
・範囲・手法
・エグゼクティブサマリー
・イントロダクション
・世界のトランスフェクション試薬＆機器市場規模：製品別
- 試薬の市場規模
- 機器の市場規模
・世界のトランスフェクション試薬＆機器市場規模：技術別
- 生化学ベーストランスフェクションの市場規模
- 物理的トランスフェクションの市場規模
- ウイルスベクターベーストランスフェクションの市場規模
・世界のトランスフェクション試薬＆機器市場規模：用途別
- 生物医学研究用トランスフェクション試薬＆機器の市場規模
- タンパク質生産用トランスフェクション試薬＆機器の市場規模
- 治療的送達用トランスフェクション試薬＆機器の市場規模
・世界のトランスフェクション試薬＆機器市場規模：エンドユーザー別
- 医薬品＆バイオテクノロジー企業における市場規模
- 学術＆研究機関における市場規模
・世界のトランスフェクション試薬＆機器市場規模：地域別
- 北米のトランスフェクション試薬＆機器市場規模
- アジア太平洋のトランスフェクション試薬＆機器市場規模
- ヨーロッパのトランスフェクション試薬＆機器市場規模
- 中南米のトランスフェクション試薬＆機器市場規模
- 中東・アフリカのトランスフェクション試薬＆機器市場規模
・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況

The global transfection reagents and equipment market size reached US$ 899.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,426.9 Million by 2028, exhibiting a growth rate (CAGR) of 7.64% during 2023-2028.

Transfection reagents and equipment help modulate gene expression in eukaryotic cells in vitro and in vivo. They allow researchers to generate stable cell lines and introduce deoxyribonucleic acid (DNA) plasmids possessing gene inserts for expression and small interfering RNA (siRNA). They are currently being used as viable analytical tools for protein synthesis, cell growth and development, and facilitating the study of genetic functions. Besides this, as they provide cost-effective and rapid production of recombinant human therapeutic proteins in sufficient quantities, transfection reagents and equipment are also gaining traction in producing r-proteins, antibodies, and viral vectors for vaccines.

Transfection Reagents and Equipment Market Trends:
Due to the outbreak of coronavirus disease (COVID-19) globally, governing agencies of numerous countries are focusing on accelerating the vaccination drive. However, due to the emergence of new variants, the protection and immunity that these vaccines provide are short-lived. As a result, there is a rise in the need of transfection reagents and equipment to develop innovative strategies or alternatively repurpose existing treatments to fight against virus infection. Apart from this, rapid detection of new cancer variants, coupled with the escalating demand for precision medicine and high-quality oncology care, are driving the adoption of transfection reagents and equipment in cancer research and drug development. Moreover, the emerging use of gene therapies to treat rare diseases caused by genetic problems is impelling the market growth. Furthermore, due to the growing number of fatal road accidents across the globe, there is a significant rise in the demand for tissue engineering to develop functional substitutes for damaged tissues. This, in turn, is propelling the market growth. Besides this, recent advancements in transfection technologies, along with increasing investments in pharmaceutical and biotechnology sectors, are anticipated to drive the market.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global transfection reagents and equipment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, technology, application and end user.

Breakup by Product:

Reagents
Equipment

Breakup by Technology:

Biochemical Based Transfection
Physical Transfection
Viral-Vector Based Transfection

Breakup by Application:

Biomedical Research
Protein Production
Therapeutic Delivery

Breakup by End User:

Pharmaceutical and Biotechnology Companies
Academics and Research Institutes

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bio-Rad Laboratories Inc., Lonza Group AG, MaxCyte Inc., Merck KGaA, Mirus Bio LLC, OriGene Technologies Inc., PerkinElmer Inc., Polyplus-transfection SA, Promega Corporation, PromoCell GmbH, Qiagen N.V. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report
1. What was the size of the global transfection reagents and equipment market in 2022?
2. What is the expected growth rate of the global transfection reagents and equipment market during 2023-2028?
3. What are the key factors driving the global transfection reagents and equipment market?
4. What has been the impact of COVID-19 on the global transfection reagents and equipment market?
5. What is the breakup of the global transfection reagents and equipment market based on the product?
6. What is the breakup of the global transfection reagents and equipment market based on the technology?
7. What is the breakup of the global transfection reagents and equipment market based on the application?
8. What is the breakup of the global transfection reagents and equipment market based on the end user?
9. What are the key regions in the global transfection reagents and equipment market?
10. Who are the key players/companies in the global transfection reagents and equipment market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Transfection Reagents and Equipment Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Reagents
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Equipment
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Technology
7.1 Biochemical Based Transfection
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Physical Transfection
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Viral-Vector Based Transfection
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Application
8.1 Biomedical Research
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Protein Production
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Therapeutic Delivery
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by End User
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academics and Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Bio-Rad Laboratories Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.1.3 Financials
15.3.1.4 SWOT Analysis
15.3.2 Lonza Group AG
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.2.3 Financials
15.3.2.4 SWOT Analysis
15.3.3 MaxCyte Inc.
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.3.3 Financials
15.3.4 Merck KGaA
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.4.3 Financials
15.3.4.4 SWOT Analysis
15.3.5 Mirus Bio LLC
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 OriGene Technologies Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 PerkinElmer Inc.
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.7.3 Financials
15.3.7.4 SWOT Analysis
15.3.8 Polyplus-transfection SA
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Promega Corporation
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 PromoCell GmbH
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 Qiagen N.V.
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
15.3.11.3 Financials
15.3.11.4 SWOT Analysis
15.3.12 Thermo Fisher Scientific Inc.
15.3.12.1 Company Overview
15.3.12.2 Product Portfolio
15.3.12.3 Financials
15.3.12.4 SWOT Analysis



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ トランスフェクション試薬＆機器の世界市場2023-2028：産業動向、シェア、規模、成長、機会・予測(Transfection Reagents and Equipment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • トランスフェクション技術の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • トランスフェクション技術の世界市場2024～2032：製品種類別、用途別、トランスフェクション方法別、技術別、エンドユーザー別、地域別
  • モノクローナル抗体の世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測

    • ◆H&Iグローバルリサーチのお客様（例）◆